跳至主要内容
临床试验/ITMCTR2000003872
ITMCTR2000003872尚未招募1 期

Evaluation of the clinical effect of Tiaozangyangfei decoction on stable phase of chronic obstructive pulmonary disease with deficiency of both lung and kidney by FRAX and bone metabolic biochemical indexes

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • (1) meet the criteria of TCM Syndrome diagnosis for stable COPD;
  • (2) aged 40 to 80 years old;
  • (3) patient denied participating in clinical trial of other drugs within 1 month;
  • (4) patient volunteered to take the trial and signed informed consent form.

排除标准

  • (1) patients with acute exacerbation of chronic obstructive pulmonary disease;
  • (2) patients with chronic wheezing and chronic cough caused by asthma, lung and bronchial tumors, Tuberculosis, bronchiectasis and allergens;
  • (3) women in pregnancy and lactation with severe heart and lung diseases;
  • (4) with primary diseases of the serious circulatory system, urinary system, digestive system, blood system, endocrine and rheumatic immune system, include patients with cancer or AIDS;
  • (5) the definition of persons with disabilities as set out in the relevant legal articles, including blindness, deafness, muteness, mental retardation, Mental Retardation, etc.;
  • (6) alcohol and certain drugs are suspected of having been abused in patients; Or other medical history that significantly reduces the likelihood of admission or complicates the whole process of admission, such as frequent changes of place of work or residence, which may result in loss of follow-up;
  • (7) patients undergoing clinical trials of other drugs in the last month.

研究者

发起方
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

相似试验

Evaluation of the clinical effect of Tiaozangyangfei... | 临床试验